Surrozen, Inc.
SRZN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001824893
In the last 90 days, Surrozen, Inc. insiders filed 0 open-market purchases and 1 sale; 70 institutions reported holding it in 13F filings for Q2 2026, worth $314.5M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Surrozen, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −2 vs. Q4 2021
- Shares held
- 22.4M
- −1.49M (−6.3%) vs. Q4 2021
- Total value
- $67.4M
- −$86.1M (−56.1%) vs. Q4 2021
- New holders
- 3
- 4 more added
- Sold out
- 5
- 9 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SRZN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 70 | $314.5M |
| Q1 2026 | 59 | $314.2M |
| Q4 2025 | 55 | $195.1M |
| Q3 2025 | 36 | $81.7M |
| Q2 2025 | 31 | $53.9M |
| Q1 2025 | 30 | $63.5M |
| Q4 2024 | 24 | $35.4M |
| Q3 2024 | 23 | $25.5M |
| Q2 2024 | 21 | $23.1M |
| Q1 2024 | 16 | $15.0M |
| Q4 2023 | 17 | $9.78M |
| Q3 2023 | 25 | $7.90M |
| Q2 2023 | 22 | $8.62M |
| Q1 2023 | 23 | $9.91M |
| Q4 2022 | 26 | $9.36M |
| Q3 2022 | 27 | $44.1M |
| Q2 2022 | 24 | $63.1M |
| Q1 2022 | 30 | $67.4M |
| Q4 2021 | 32 | $153.5M |
| Q3 2021 | 29 | $150.7M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Surrozen, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 134 | $0 | 0.00% | −5−3.6% | Reduced |
| Morgan Stanley | 30 | $0 | 0.00% | −52−63.4% | Reduced |
| JPMorgan Chase & Co | 52 | $0 | 0.00% | +52 | New |
| Private Capital Group, LLC | 300 | $1.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 372 | $1.00K | 0.00% | +367+7,340.0% | Added |
| Tower Research Capital LLC (TRC) | 2,323 | $7.00K | 0.00% | +2,323 | New |
| Penserra Capital Management LLC | 7,135 | $21.0K | 0.00% | +2,648+59.0% | Added |
| Wolverine Asset Management LLC | 8,746 | $26.0K | 0.00% | −426−4.6% | Reduced |
| BlackRock Inc. | 36,199 | $109.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 37,988 | $114.0K | 0.00% | 00.0% | Unchanged |
| Jasper Ridge Partners, L.P. | 46,838 | $141.0K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 70,932 | $214.0K | 0.00% | +3,632+5.4% | Added |
| Prelude Capital Management, LLC | 73,843 | $222.0K | 0.01% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 77,723 | $234.0K | 0.00% | −335,723−81.2% | Reduced |
| Bank of Montreal | 110,178 | $377.0K | 0.00% | +110,178 | New |
| Geode Capital Management, LLC | 172,370 | $518.0K | 0.00% | +15,651+10.0% | Added |
| Hudson Bay Capital Management LP | 195,400 | $588.0K | 0.01% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 300,000 | $903.0K | 0.23% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 305,648 | $920.0K | 0.01% | −91,080−23.0% | Reduced |
| Empery Asset Management, LP | 333,965 | $1.00M | 4.72% | −246,735−42.5% | Reduced |
| Laurion Capital Management LP | 364,503 | $1.10M | 0.03% | −155,497−29.9% | Reduced |
| Vanguard Group Inc | 470,742 | $1.42M | 0.00% | −158,943−25.2% | Reduced |
| Bridger Management, LLC | 700,001 | $2.11M | 0.35% | 00.0% | Unchanged |
| Euclidean Capital LLC | 802,963 | $2.42M | 1.40% | −10.0% | Reduced |
| Board of Trustees of The Leland Stanford Junior University | 806,374 | $2.43M | 0.14% | 00.0% | Unchanged |
| Harvard Management Co Inc | 826,852 | $2.49M | 0.25% | 00.0% | Unchanged |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 1,200,000 | $3.61M | 0.08% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 2,500,000 | $7.53M | 0.04% | 00.0% | Unchanged |
| Consonance Capital Management LP | 3,497,500 | $10.5M | 17.86% | 00.0% | Unchanged |
| The Column Group LLC | 9,414,795 | $28.3M | 5.25% | 00.0% | Unchanged |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −350,000−100.0% | Sold out |
| Boxer Capital, LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Nan Fung Group Holdings Ltd | 0 | $0 | 0.00% | −65,070−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −12,600−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −11,442−100.0% | Sold out |